Company: TVRD
Filing Date: 2025-02-14
Form Type: S-4/A
Source: 0001104659-25-013053
Chunk: 946

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-02-14
Form: S-4/A
Chunk 946
---
 | ​ |

The weighted-average discount rate and remaining lease term were as follows:

| ​                                     | ​ | ​ | As ofSeptember 30,2024 |   |       |   | ​ | ​ | As ofDecember 31,2023 |   |       |   | ​ |
| Weighted-average discount rate        | ​ | ​ | ​                      | ​ | 9.50% | ​ | ​ | ​ | ​                     | ​ | 9.50% | ​ | ​ |
| Weighted-average remaining lease term | ​ | ​ | ​                      | ​ |  2.92 | ​ | ​ | ​ | ​                     | ​ |  3.67 | ​ | ​ |

F-124

TABLE OF CONTENTS

Tvardi Therapeutics, Inc. Notes to CONDENSED Financial Statements
(Unaudited) As of September 30, 2024, the maturities of the Company’s operating lease liabilities were as follows (in thousands):

| Year Ended December 31,                             
 2024 (remaining three months)                       | ​ 
 ​ | ​ 
 ​ | Amount 
 ​      |   |  31 | ​ | ​ 
 ​ |
|:----------------------------------------------------|:--|:--|:-------|:--|----:|:--|:--|
| 2025                                                | ​ | ​ | ​      | ​ |  94 | ​ | ​ |
| 2026                                                | ​ | ​ | ​      | ​ | 129 | ​ | ​ |
| 2027                                                | ​ | ​ | ​      | ​ |  88 | ​ | ​ |
| Total lease payments                                | ​ | ​ | ​      | ​ | 342 | ​ | ​ |
| Less: imputed interest                              | ​ | ​ | ​      | ​ | -43 | ​ | ​ |
| Present value of lease liabilities                  | ​ | ​ | ​      | ​ | 299 | ​ | ​ |
| Less: operating lease liabilities, current portion  | ​ | ​ | ​      | $ |  92 | ​ | ​ |
| Operating lease liabilities, net of current portion | ​ | ​ | ​      | $ | 207 | ​ | ​ |

8. Redeemable Convertible Preferred Stock The Company has issued Series A preferred stock and Series B preferred stock, which are collectively referred to as the Preferred Stock. As of September 30, 2024 and December